Patent: 9,994,550
✉ Email this page to a colleague
Summary for Patent: 9,994,550
Title: | Heterocyclic modulators of lipid synthesis for use against cancer and viral infections |
Abstract: | Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds. |
Inventor(s): | Wagman; Allan S. (Belmont, CA), Johnson; Russell J. (Sunnyvale, CA), Zaharia; Cristiana A. (Redwood City, CA), Cai; Haiying (Cupertino, CA), Hu; Lily W. (Palo Alto, CA), Duke; Greg (Menlo Park, CA), Ohol-Gupta; Yamini (Menlo Park, CA), Heuer; Timothy (Menlo Park, CA), O\'Farrell; Marie (Menlo Park, CA) |
Assignee: | 3-V Biosciences, Inc. (Menlo Park, CA) |
Application Number: | 15/110,154 |
Patent Claims: | see list of patent claims |
Details for Patent 9,994,550
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2034-01-07 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2034-01-07 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2034-01-07 |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2034-01-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |